Dr. Ahemd AK Hassoun

Dr. Ahemd AK Hassoun

Verified
Consultant
  • Endocrinologist
MD
Experience
31 yrs
Rating
★ 5.0 (12)
AboutEducationAwardsSimilar doctorsFAQ

About Dr. Ahemd AK Hassoun

  • Dr. Ahemd AK Hassoun is an American Board Certified Endocrinologist possessing 28+ years of experience within the endocrinology domain.
  • He is well trained in treating all types of diabetes, obesity, thyroid diseases & tumors, hypertensive disorder, etc.
  • He attained fellowships from the American College of Physicians and the American College of Endocrinology.
  • He is professionally affiliated with various organizations including the American Diabetes Association (ADA), the Endocrine Society (ES), and the American Association of Clinical Endocrinologists (AACE).
  • He plays a key role in developing and updating the UAE Diabetes guidelines, educating and training doctors and other healthcare providers in the endocrinology domain. 
  • He is a co-founder of the monthly UAE Endocrinology meetings (Endocrine club), which was established in the year 2002.
  • He bagged several awards including the 2019 ‘Ibn Sina Distinguished Service Award’ the American Association of Clinical Endocrinologists – Gulf Chapter.
  • He has authored and co-authored over 50 articles in the area of endocrinology.

Location

  • VerifiedMD, Aleppo University Faculty of Medicine, Aleppo, Syria(1979)
  • VerifiedFellowship, Fellowship, American College of Physicians & American College of Endocrinology

Papers Published

  • Factors predicting the development of diabetic retinopathy in patients with diabetes at the Dubai Diabetes Center) (ongoing)
+ Read More
  • Effect and safety of Semaglutide 2.4 mg once weekly in subjects with overweight or obesity and type 2 diabetes (Step 2) (ongoing)
  • Depression, diabetes distress and quality of life among diabetic patients attending Dubai Diabetes Center
  • Diabetes distress and depression and its effect on glycemic control in a sample of adolescent patients with type 1 diabetes attending a diabetes center in Dubai, United Arab Emirates
  • Real-world assessment of clinical outcome changes – including the month of Ramadan – for dapagliflozin in management of type 2 diabetes mellitus (reward study)

A few of his many publications and abstracts include:

  • The effect of frequent diabetes self-management education on glucose control in patients with diabetes at the Dubai Diabetes Center – Journal of diabetes and endocrine practice. Volume 2; Issue 1, January-March 2019
  • Interaction between angiotensin-converting enzyme (ace) insertion/deletion and aldosterone synthase (cyp11b2) – 344c/t polymorphisms in relation to type 2 diabetes mellitus risk in Emiratis. International Journal of Genetics and Molecular Biology; 2013; 5(2), pp. 20-27
  • Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the middle east region. The Journal of International Medical Research. 2011: 39 (2): 366-377
  • Hepatitis C-associated osteosclerosis: an unusual syndrome of acquired osteosclerosis in adults. Am J Med. 1997 Jul. 103 (1): 70-3
  • Glycated hemoglobin in insulinoma. Endocrine practice. 1998 July/August; 4(4): 181-183
  • Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: results of the canagliflozin in Ramadan tolerance observational study (cratos). Int j clin pract. 2017 Oct;71(10). Doi: 10.1111/ijcp.12991. Epub 2017 Aug 29.
  • Elevated hemoglobin a1c is significantly associated with decreased post-exercise heart rate recovery in parents with diabetes mellitus. Intj diabetes clin res 2017, 4:074.
  • Self-efficacy, self-care and glycemic control in Saudi Arabian patients with type 2 diabetes mellitus. Diabetes res Clin pract. 2017 Dec 24;137:28-36.
  • Goal study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice. BMJ open diabetes res care. 2018 Jul 10;6(1)
  • The diabetes epidemic: investigating the association between t2dm and tcf7l2 gene variants in the emirati population. Accepted for publication in American journal of human biology.
  • Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population. Accepted for publication in “gene”
  • Emirates diabetes society consensus guidelines for the management of type 2 diabetes mellitus-2020. Accepted at Dubai diabetes and endocrinology journal
  • The effect of frequent diabetes self-management education on glucose control in patients with diabetes at the Dubai diabetes center in Dubai, United Arab Emirates. Journal of diabetes and endocrine practice. Volume 2; issue 1, January-March 2019
  • The effect of vildagliptin relative to sulphonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the middle east: the virtue study. Curr med res opin. 2017 jan;33(1):161-167. Epub 2016 oct 14.

Send Your Enquiry

Fill in your details and our medical experts will contact you within 24 hours.

By submitting I agree to the Terms of Use and Privacy Policy of Vaidam Health.

Want to consult the doctor?

Don't Ignore Your Health!

Other Top Endocrinologist In Dubai

Dr. Abdul Jabbar

Dr. Abdul Jabbar

Endocrinologist
Medcare Hospital Al Safa · Dubai
37+ years of experience
Chat IconChat
Dr. Emran Ghaffar Khan

Dr. Emran Ghaffar Khan

Endocrinologist
King's College Hospital, Dubai · Dubai
21+ years of experience
Chat IconChat

FAQ's About Dr. Ahemd AK Hassoun

Where does Dr. Ahemd AK Hassoun practice?

Dr. Ahemd AK Hassoun practices at Fakeeh University Hospital, Dubai

What is the specialty of Dr. Ahemd AK Hassoun?

Dr. Ahemd AK Hassoun specialty is Endocrinologist

What is the experience of Dr. Ahemd AK Hassoun?

Dr. Ahemd AK Hassoun is Endocrinologist with 31 years of experience.

Our Network

500+

Top Hospitals

10,000+

Doctors

50+

Cities

10+

Countries

Need Assistance?Chat